Skip to main content
SpringerLink
Log in

The Rappaport classification of the non-Hodgkin’s lymphomas: Is it pertinent for the 1980’s?

  • Chapter
Controversies in the Management of Lymphomas

Part of the book series: Cancer Treatment and Research ((CTAR,volume 16))

Abstract

Prior to the proposal of the so-called ‘Rappaport classification’ [1] malignant lymphomas were divided into four types — Hodgkin’s disease [2], lymphosarcoma [3], reticulum cell sarcoma [4,5], and follicular lymphoblastoma [6]. The morphologic criteria for recognition of the latter three types of malignant lymphoma were vague, and different investigators often designated the same tumor by different names. Because of a lack of uniformity in diagnoses, no meaningful correlations could be established between the histologic types of lymphomas and their clinical behavior.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Rappaport H, Winter WJ, Hicks EB: Follicular lymphoma. A re-evaluation of its position in the scheme of malignant lymphoma, based on a survey of 253 cases. Cancer 9: 792–821, 1956.

    PubMed  Google Scholar 

  2. Hodgkin T: On some morbid appearances of the absorbent glands and spleen. Trane Med Chir Soc Lond 17: 68–114, 1832.

    CAS  Google Scholar 

  3. Virchow RLK : Die Krankhaftern Geschwuelste 2:728–738 Berlin: Hirschwald, 1863.

    Google Scholar 

  4. Roulet F: Das primare Retothelsarkom der Lymphknoten. Virchows Arch [Pathol Anat] 277: 15–47, 1930.

    Google Scholar 

  5. Roulet F: Oeitere Beitrage zur Kenntnis des Retothelsarkoms der Lymphknoten und anderer Lymphoiden-Organe. Virchows Arch [Pathol Anat] 286: 702–732, 1932.

    Google Scholar 

  6. Baehr G: The clinical and pathological picture of follicular lymphoblastoma. Trans Assoc Am Phys 47: 330–338, 1932.

    Google Scholar 

  7. Rappaport H: Tumors of the hematopoietic system. In: Atlas of tumor pathology, Section III, Fasicle 8. Washington D.C. Armed Forces Institute of Pathology, pp. 97–161, 1966.

    Google Scholar 

  8. Berard CW, O’Conor GT, Thomas LB, Torloni H: Histopathological definition of Burkitt’s tumor. Bull WHO 40: 601–607, 1969.

    Google Scholar 

  9. Berard CW: Chapter 15 Reticuloendothelial System: An overview of neoplasia. In: International Academy of pathology Monograph No. 16: The Reticuloendothelial System, JW Rebuck, CW Berard, MR Abell (eds.), Baltimore: Williams and Wilkins, 1975, pp. 301–317.

    Google Scholar 

  10. Jones SE, Fuks Z, Bull M, Kadin ME, Dorfman RF, Kaplan HS, Rosenberg SA, Kim H: Non-Hodgkin’s lymphomas IV. Clinicopathologic correlation in 405 cases. Cancer 31: 806–823, 1973.

    PubMed  CAS  Google Scholar 

  11. Schein PS, Chabner BA, Canellos GP, Young RC, Berard C, DeVita VT: Potential for prolonged disease-free survival following combination chemotherapy of non-Hodgkin’s lymphoma. Blood 43: 181–189, 1974.

    PubMed  CAS  Google Scholar 

  12. Bloomfield CD, Goldman A, Dick F, Brunning RD, Kennedy BJ: Multivariate analysis of prognostic factors in the non-Hodgkin’s malignant lymphoma. Blood 43: 181–189, 1974.

    Google Scholar 

  13. Patchefsky AS, Brodovsky HS, Menduke H, Southard M, Brooks J, Nicklas D, Hoch WS: Non-Hodgkin’s Lymphomas: A clinicopathologic study of 293 cases. Cancer 34: 1173–1186, 1974.

    PubMed  CAS  Google Scholar 

  14. Brown TC, Peters MV, Bergsagel DE, Reid J: A retrospective analysis of the clinical results in relation to the Rappaport histological classification. Br J Cancer (Suppl. 11) 31: 174–186, 1975.

    Google Scholar 

  15. DeVita VT Jr, Canellos GP, Chabner B, Schein P, Hubbard SP, Young RC: Advanced diffuse histiocytic lymphoma, a potentially curable disease. Lancet 1: 248–250, 1975.

    Google Scholar 

  16. Schein PS, DeVita VT, Hubbard S, Chabner BA, Canellos GP, Berard C, Young RC: Bleomycin, adriamycin, cyclophosphamide, vincristine, and prednisone (BACOP) com-bination chemotherapy in the treatment of advanced diffuse histiocytic lymphoma. Ann Intern Med 85: 417–422, 1976.

    PubMed  CAS  Google Scholar 

  17. Lennert K, Niedorf HR: Nachweis von desmosomal verknupften reticulumzellen im follikularen lymphom (Brill Symmers). Virchows Archiv 4: 148–150, 1969.

    CAS  Google Scholar 

  18. Kojima M, Imai Y, Mori N: A concept of follicular lymphoma. A proposal for the existence of a neoplasm originating from the germinal center. In: Malignant Diseases of the Hematopoietic System. GANN Monograph on Cancer Research No. 15, K. Akazaki, H. Rappaport, CW Berard, JM Bennett, E. Ishikawa (eds.), Tokyo: University of Tokyo Press, 1973, pp. 195–207.

    Google Scholar 

  19. Glick AD, Leech JH, Waldron JA, Flexner JM, Horn RG, Collins RD: Malignant lymphomas of follicular center cell origin in man. II Ultrastructural and cytochemical studies. J Natl Cancer Inst 54: 23–27, 1975.

    PubMed  CAS  Google Scholar 

  20. Levine GD, Dorfman RF: Nodular lymphoma: An ultrastructural study of its relationship to germinal centers and a correlation of light and electron microscopic findings. Cancer 35: 148–164, 1975.

    PubMed  CAS  Google Scholar 

  21. Dorfman RF: Enzyme histochemistry of normal, hyperplastic, and neoplastic lymphoreticular tissues. In: Symposium on Lymphoreticular Tumours in Africa, Roulet, FC (ed.), Paris, Basel, Switzerland, New York, S. Karger 1964, pp. 304–326.

    Google Scholar 

  22. Aisenberg AC, Bloch KJ: Immunoglobulins on the surface of neoplastic lymphocytes. New Eng J Med 287: 272–276, 1972.

    PubMed  CAS  Google Scholar 

  23. Preud’homme JL, Seligmann M: Surface bound immunoglobulins as a cell marker in human lymphoproliferative diseases. Blood 40: 777–794, 1972.

    PubMed  Google Scholar 

  24. Braylan RC, Rappaport H: Tissue immunoglobulins in nodular lymphomas as compared with reactive follicular hyperplasias. Blood 42: 579–589, 1973.

    PubMed  CAS  Google Scholar 

  25. Braylan RC, Jaffe ES, Berard CW: Malignant lymphomas: Current classification and new observations. In: Pathology Annual, Sommers, SC (ed.), New York: Appleton-Century- Crofts, 1975, pp. 213–217.

    Google Scholar 

  26. Brouet JC, Labaume S, Seligmann M: Evaluation of T and B lymphocyte membrane markers in human non-Hodgkin malignant lymphomata. Br J Cancer (Suppl. 11) 31: 121–127, 1975.

    Google Scholar 

  27. Dorfman RF: The non-Hodgkin’s lymphomas. In: The Reticuloendothelial System. IAP Monograph No. 16, JW Rebuck, CW Berard, MR Abell (eds.), Baltimore: Williams and Wilkins, 1975, pp. 262–281.

    Google Scholar 

  28. Leech JH, Glick AD, Waldron JA, Flexner JM, Horn RG, Collins RD: Malignant lymphomas of follicular center cell origin in man. I. Immunologic studies. J Natl Cancer Inst 54: 11–21, 1975.

    PubMed  CAS  Google Scholar 

  29. Taylor CR: An immunohistological study of follicular lymphoma, reticulum cell sarcoma and Hodgkin’s disease. Eur J Cancer 12: 61–75, 1976.

    PubMed  CAS  Google Scholar 

  30. Pangalis GA, Rappaport H: Common clonal origin of lymphoplasmacytic proliferation and immunoblastic lymphoma in intestinal a-chain disease. Lancet 1977; 2: 880.

    PubMed  CAS  Google Scholar 

  31. Warnke R, Pederson M, Williams C, Levy R: A study of lymphoproliferative diseases comparing immunofluorescence with immunohistochemistry. Am J Clin Pathol 70: 867–875, 1978.

    Google Scholar 

  32. Issacson P, Wright DH: Anomalous staining patterns in immunohistologic studies of malignant lymphoma. J Histochem Cytochem 27: 1197–1199, 1979.

    Google Scholar 

  33. Banks PM: Diagnostic applications of an immunoperoxidase method in hematopathology. J Histochem Cytochem 27: 1192 1194, 1979.

    Google Scholar 

  34. Pangalis GA, Nathwani BN, Rappaport H: Detection of cytoplasmic immunoglobulin in well-differentiated lymphoproliferative diseases by the immunoperoxidase method. Cancer 45: 1334–1339, 1980.

    PubMed  CAS  Google Scholar 

  35. Tubbs RR, Sheibani K, Sebek BA, Weiss RA: Immunohistochemistry versus immu-nofluorescence for non-Hodgkin’s lymphomas. Am J Clin Pathol 73: 144–145, 1980.

    PubMed  CAS  Google Scholar 

  36. Jaffe ES, Shevach EM, Frank MM, Berard CW, Green I: Nodular lymphoma - Evidence for origin from follicular B lymphocytes. N Engl J Med 290: 813–819, 1974.

    PubMed  CAS  Google Scholar 

  37. Cossman J, Jaffe ES: Distribution of complement receptor subtypes in non-Hodgkin’s lymphomas of B-cell origin. Blood 58: 20–26, 1981.

    PubMed  CAS  Google Scholar 

  38. Warnke R, Levy R: Detection of T and B cell antigens with hybridoma monoclonal antibodies: a biotin-avidin-horseradish peroxidase method. J Histochem Cytochem 28: 771–776, 1980.

    PubMed  CAS  Google Scholar 

  39. Lampson L, Levy R: Two populations of la-like molecules on a human B cell line. J Immunol 125: 293–299, 1980.

    PubMed  CAS  Google Scholar 

  40. Engleman EG, Warnke R, Fox RI, Dilley J, Benike CJ, Levy R: Studies of a human T lymphocyte antigen recognized by a monoclonal antibody. Proc Natl Acad Sci USA 78: 1791–1795, 1981.

    PubMed  CAS  Google Scholar 

  41. Poppema S, Bhan AK, Reinherz EL, McCluskey RT, Schlossman SF: Distribution of T cell subsets in human lymph nodes. J Exp Med 153: 30–41, 1981.

    PubMed  CAS  Google Scholar 

  42. Payne BC, Kim H, Pangalis GA, Rothman A, Rappaport H: A method for the ultrastructural demonstration of non-specific esterase in human blood and lymphoid tissue. Histochem J 12: 71–86, 1980.

    PubMed  CAS  Google Scholar 

  43. Kim H, Pangalis GA, Payne BC, Kadin ME, Rappaport H: Ultrastructural identification of neoplastic histiocytes-monocytes. An application of a newly developed cytochemical technique. Am J Pathol 106: 204–223, 1982.

    PubMed  CAS  Google Scholar 

  44. Braylan RC, Fowlkes BJ, Jaffe ES, Sanders SK, Berard CW, Herman CJ: Cell volumes and DNA distributions of normal and neoplastic human lymphoid cells. Cancer 41: 201–209, 1978.

    PubMed  CAS  Google Scholar 

  45. Shackney SE, Skramstad KS: A dynamic interpretation of multiparameter studies in the lymphomas. Am J Clin Pathol 72: 756–764, 1979.

    PubMed  CAS  Google Scholar 

  46. Diamond LW, Braylan RC: Flow analysis of DNA content and cell size in non-Hodgkin’s lymphoma. Cancer Res 40: 703–712, 1980.

    PubMed  CAS  Google Scholar 

  47. Lukes RJ, Collins RD: Immunologic characterization of human malignant lymphomas. Cancer 34: 1488–1503, 1974.

    PubMed  Google Scholar 

  48. Lennert K, Mohri N, Stein H, Kaiserling E: The histopathology of malignant lymphoma. Br J Haematol (Suppl.) 31: 193–203, 1975.

    Google Scholar 

  49. Mann RB, Jaffe ES, Braylan RC, Nanba K, Frank MM, Ziegler JL, Berard CW: Non- endemic Burkitt’s lymphoma: A B-cell tumor related to germinal centers. N Engl J Med 295: 685–691, 1976.

    PubMed  CAS  Google Scholar 

  50. Mann RB, Jaffe ES, Berard CW: Malignant lymphomas: a conceptual understanding of morphologic diversity. Am J Pathol 94: 105–192, 1979.

    PubMed  CAS  Google Scholar 

  51. Berd D, Cornog J, DeConti RC, Levitt M, Bertino JR: Long term remission in diffuse histiocytic lymphoma treated with combination sequential chemotherapy. Cancer 35: 1050–1054, 1975.

    PubMed  CAS  Google Scholar 

  52. Bitran JD, Kinzie J, Sweet DL, Variakojis D, Griem ML, Golomb HM, Miller JB, Oetzel N, Ultmann JE: Survival of patients with localized histiocytic lymphoma. Cancer 39: 342–346, 1977.

    PubMed  CAS  Google Scholar 

  53. Fisher RI, DeVita VT, Johnson BL, Simon R, Young RC: Prognostic factors for advanced diffuse histiocytic lymphoma following treatment with combination chemotherapy. Am J Med 63: 177–182, 1977.

    PubMed  CAS  Google Scholar 

  54. Elias L, Portlock CS, Rosenberg SA: Combination chemotherapy of diffuse histiocytic lymphoma with cyclophosphamide, adriamycin, vincristine and prednisone (CHOP). Cancer 42: 1705–1710, 1978.

    PubMed  CAS  Google Scholar 

  55. Skarin A, Canellos G, Rosenthal D, Moloney W, Frei E: Therapy of unfavorable histology and non-Hodgkin’s lymphoma (NHL) with high dose methotrexate and citrovorum factor rescue (MTX/CF), bleomycin, (B), adriamycin, (A), cyclophosphamide (C), oncovin (o), and decadron (D) (M-BACOD). (Abstr) Am Assoc Cancer Res/Am Soc Clin Oncol Proc 19: 400, 1978.

    Google Scholar 

  56. Jones SE, Grozea PN, Metz EN, Haut A, Stephens RL, Morrison FS, Butler JJ, Byrne GE Jr, Moon TE, Fisher R, Haskins CL, Coltman CA Jr: Superiority of adriamycin-containing combination chemotherapy in the treatment of diffuse lymphoma. Cancer 43: 417–425, 1979.

    PubMed  CAS  Google Scholar 

  57. Sweet DL, Golomb HM, Ultmann JE, Miller B, Stein RS, Lester EP, Mintz U, Bitran JD, Streuli RA, Daly K, Roth NO: Cyclophosphamide, vincristine, methotrexate with leuco-vorin rescue, and cytarabine (COMLA) combination sequential chemotherapy for advanced diffuse histiocytic lymphoma. Ann Int Med 92: 785–790, 1980.

    PubMed  CAS  Google Scholar 

  58. National Cancer Institute sponsored study of classifications of non-Hodgkin’s lymphoma. Summary and description of a working formulation for clinical usage. The non-Hodgkin’s lymphoma pathologic classification project. Cancer 49: 2112–2135, 1982.

    Google Scholar 

  59. Nathwani BN, Kim H, Rappaport H, Solomon J, Fox M: Non-Hodgkin’s lymphoma: A clinicopathological study comparing two classifications. Cancer 41: 303–325, 1978.

    PubMed  CAS  Google Scholar 

  60. Strauchen JA, Young RC, DeVita VT, Anderson T, Fantone JC, Berard CW: Clinical relevance of the histopathological subclassification of diffuse ‘histiocytic’ lymphoma. N Engl J Med 299: 1382–1387, 1978.

    PubMed  CAS  Google Scholar 

  61. Berard CW, Jaffe ES, Braylan RC, Mann RB, Nanba K: Immunologic aspects and pathology of the malignant lymphomas. Cancer 42: 911–921, 1978.

    PubMed  CAS  Google Scholar 

  62. Armitage JO, Dick FR, Platz CE, Corder MP, Leimert JT: Clinical usefulness and reproducibility of histologic subclassification of advanced diffuse histiocytic lymphoma. Am J Med 67: 929–934, 1979.

    PubMed  CAS  Google Scholar 

  63. Fisher RI, Hubbard SM, DeVita VT, Berard CW, Wesley R, Cossman J, Young RC: Factors predicting long-term survival in diffuse mixed, histiocytic or undifferentiated lymphoma. Blood 58: 45–51, 1981.

    PubMed  CAS  Google Scholar 

  64. Whitcomb CC, Cousar JB, Flint A, Crissman JD, Bartolucci AA, Durant JR, Gams RA, Collins RD, Byrne GE Jr: Subcategories of histiocytic lymphoma: Associations with survival and reproducibility of classification. The Southeastern Cancer Study Group Experience. Cancer 48: 2464–2474, 1981.

    PubMed  CAS  Google Scholar 

  65. Foucar K, Armitage JO, Dick F: The clinical and pathologic features of diffuse mixed non- Hodgkin’s lymphoma. (Abstr) Blood 58 (Suppl. l): 158a, 1981.

    Google Scholar 

  66. Newcomer LN, Nerenberg MI, Cadman EC, Waldron JA Jr, Farber LR, Bertino JR: The usefullness of the Lukes-Collins classification in identifying subsets of diffuse histiocytic lymphoma responsive to chemotherapy. Cancer 50: 439–443, 1982.

    PubMed  CAS  Google Scholar 

  67. Warnke RA, Strauchen JA, Burke JS, Hoppe RT, Campbell BA, Dorfman RF: Morphologic types of diffuse large-cell lymphoma. Cancer 50: 690–695, 1982.

    PubMed  CAS  Google Scholar 

  68. Nathwani BN, Dixon DO, Jones SE, Hartsock RJ, Rebuck JW, Byrne GE Jr, Sheehan WW, Kim H, Coltman CA Jr, Rappaport H: The clinical significance of the morphological subdivision of diffuse ‘histiocytic’ lymphoma: A study of 162 patients treated by the Southwest Oncology Group. Blood 60: 1068–1074, 1982.

    PubMed  CAS  Google Scholar 

  69. Brouet JC, Preud’Homme JL, Flandrin G, Chelloul N, Seligmann M: Membrane markers in histiocytic lymphoma (reticulum cell sarcomas). J Natl Cancer Inst 56: 631–633, 1976.

    PubMed  CAS  Google Scholar 

  70. Bloomfield CD, Kersey JH, Brunning RD, Gajl-Peczlaska KJ: Prognostic significance of lymphocyte surface markers in adult non-Hodgkin’s malignant lymphoma. Lancet 2: 1330–1333, 1976.

    PubMed  CAS  Google Scholar 

  71. Epstein AL, Levy R, Kim H, Henle W, Henle G, Kaplan HS: Biology of the human malignant lymphomas. IV. Functional characterization of ten diffuse histiocytic lymphoma cell lines. Cancer 42: 2379–2391, 1978.

    PubMed  CAS  Google Scholar 

  72. Bloomfield CD, Gajl-Peczalska KJ, Frizzera G, Kersey JH, Goldman, AI: Clinical utility of lymphocyte surface markers combined with the Lukes-Collins histologic classification in adult lymphoma. N Engl J Med 301: 512–518, 1979.

    PubMed  CAS  Google Scholar 

  73. Frizzera G, Gajl-Peczalska KJ, Bloomfield CD, Kersey JH: Predictability of immunologic phenotype of malignant lymphomas by conventional morphology: a study of 60 cases. Cancer 43: 1216–1224, 1979.

    PubMed  CAS  Google Scholar 

  74. Jaffe ES, Strauchen JA, Berard CW: Predictability of immunologic phenotype by morphologic criteria in diffuse aggressive non-Hodgkin’s lymphomas. Am J Clin Pathol 77: 46–49, 1982.

    PubMed  CAS  Google Scholar 

  75. Warnke R, Miller R, Grogan T, Pederson M, Dilley J, Levy R: Immunologic phenotype in 30 patients with diffuse large cell lymphoma. N Engl J Med 303: 293–300, 1980.

    PubMed  CAS  Google Scholar 

  76. Rudders RA, Ahl ET, DeLellis RA: Surface marker and histopathologic correlation with long-term survival in advanced large cell non-Hodgkin’s lymphoma. Cancer 47: 1329–1335, 1981.

    PubMed  CAS  Google Scholar 

  77. No well PC: Phytohemagglutinin: An initiator of mitosis in cultures of normal human leukocytes. Cancer Res 20: 462–466, 1960.

    CAS  Google Scholar 

  78. Biberfield P: Morphogenesis in blood lymphocytes stimulated with phytohaemagglutinin (PH): A light and electron microscopic study. Acta Pathol Microbiol Scand (A) (Suppl.) 223: 1–70, 1971.

    Google Scholar 

  79. Cottier H, Turk J, Sobin L: A proposal for a standardized system of reporting human lymph node morphology in relation to immunological function. Bull WHO 47: 375–417, 1972.

    PubMed  CAS  Google Scholar 

  80. Dorfman RF: Classification of non-Hodgkin’s lymphomas. Lancet 1: 1295, 1974.

    PubMed  CAS  Google Scholar 

  81. Nathwani BN, Kim H, Rappaport H: Malignant lymphoma, lymphoblastic. Cancer 38: 964–983, 1976.

    PubMed  CAS  Google Scholar 

  82. Jaffe ES, Braylan RC, Frank MM, Green I, Berard CW: Functional markers: A new perspective on malignant lymphomas. Cancer Treat Rep 61: 953–962, 1977.

    PubMed  CAS  Google Scholar 

  83. Nanba K, Jaffe ES, Braylan RC, Soban EJ, Berard CW: Alkaline phosphatase positive malignant lymphomas: A subtype of B-cell lymphomas. Am J Clin Pathol 68: 535–542, 1977.

    PubMed  CAS  Google Scholar 

  84. DeVita VT, Rappaport H, Frei E, III: Announcement of formation of: The Lymphoma Task Force and Pathology Reference Center. Cancer 2: 1087–1088, 1968.

    Google Scholar 

  85. Kim H, Zelman RJ, Fox MA, Bennet JM, Berard CW, Butler JJ, Byrne GE Jr, Dorfman RF, Hartsock RJ, Lukes RJ, Mann RB, Neiman RS, Rebuck JW, Sheehan WW, Variakojis D, Wilson JF, Rappaport H: Pathology Panel for lymphoma Clinical Studies: A comprehensive analysis of cases accumulated since its incention. J Natl Cancer Inst 68: 43–67, 1982.

    PubMed  CAS  Google Scholar 

  86. Frizzera G, Moran EM, Rappaport H: Angio-immunoblastic lymphadenopathy with dys- proteinaemia. Lancet 1: 1070–1073, 1974.

    PubMed  CAS  Google Scholar 

  87. Barcos MP, Lukes RJ: Malignant lymphoma of convoluted lymphocytes - A new entity of possible T-cell type. In: Conflicts in childhood cancer. An evaluation of current manage-ment, Vol. 4, Sinks LF, Godden JO (eds.), New York: Alan R. Liss, 1975, pp. 147–178.

    Google Scholar 

  88. Banks PM, Arsenau JC, Gralnick HR, Canellos GP, DeVita Jr VT, Berard CW: American Burkitt’s lymphoma: A clinicopathologic study of 30 cases. II. Pathologic correlations. Am J Med 58: 322–329, 1975.

    PubMed  CAS  Google Scholar 

  89. Kim H, Jacobs C, Warnke RA, Dorfman RF: Malignant lymphoma with a high content of epithelioid histiocytes: A distinct clinicopathologic entity and a form of so-called ‘Lennert’s lymphoma’. Cancer 41: 620–635, 1978.

    PubMed  CAS  Google Scholar 

  90. Burke JS, Butler JJ: Malignant lymphoma with a high content of epitheliod histiocytes (Lennert’s lymphoma). Am J Clin Pathol 66: 1–9, 1976.

    PubMed  CAS  Google Scholar 

  91. Pangalis GA, Nathwani BN, Rappaport H: Malignant lymphoma, well differentiated lymphocytic: Its relationship with vchronic lymphocytic leukemia and macroglobulinemia of Waldenstrom. Cancer 39: 999–1010, 1977.

    PubMed  CAS  Google Scholar 

  92. Nathwani BN, Rappaport H, Moran EM, Pangalis GA, Kim H: Malignant lymphoma arising in angio-immunoblastic lymphadenopathy. Cancer 41: 578–606, 1978.

    PubMed  CAS  Google Scholar 

  93. Pangalis GA, Moran EM, Rappaport H: Blood and bone marrow findings in angioim- munoblastic lymphadenopathy. Blood 51: 71–83, 1978.

    PubMed  CAS  Google Scholar 

  94. Rappaport H, Pangalis GA, Nathwani BN: The evolution of immunoblastic lymphomas in morphologically non-neoplastic immunoproliferative diseases. In: Cold Springs Harbor Conferences on Cell Proliferation, Vol 5. Differentiation of normal and neoplastic hema-topoietic cells, Clarkson B, Marks PA, Tills JA (eds.), 1978, pp. 877–897.

    Google Scholar 

  95. Pangalis GA, Nathwani BN, Rappaport H, Rosen RB: Acute lymphoblastic leukemia: The significance of nuclear convolutions. Cancer 43: 551–557, 1979.

    PubMed  CAS  Google Scholar 

  96. Kim H, Nathwani BN, Rappaport H: So-called ‘Lennert’s lymphoma’: Is it a clinicopathologic entity? Cancer 45: 1379–1399, 1980.

    PubMed  CAS  Google Scholar 

  97. Rappaport H: Non-Hodgkin’s lymphoma: Roundtable discussion of histopathologic classi-fications. Cancer Treat Rep 61: 1037–1042, 1977.

    Google Scholar 

  98. Nathwani BN, Winberg CD, Diamond LW, Bearman RM, Kim H: Morphologic criteria for the differentiation of follicular lymphoma from florid reactive follicular hyperplasia: a study of 80 cases. Cancer 48: 1974–1806, 1981.

    Google Scholar 

  99. Osborne BM, Butler JJ, Variakojis D, Kott, M: Reactive Lymph node hyperplasia with giant follicles. Am J Clin Pathol 78: 693–499, 1982.

    Google Scholar 

  100. Arseneau JC, Canellos GP, Banks PM, Berard CW, Gralnick HR, DeVita VT Jr: American Burkitt’s lymphoma: A clinicopathologic study of 30 cases. I. Clinical factors relating to prolonged survival. Am J Med 58: 314–321, 1975.

    PubMed  CAS  Google Scholar 

  101. Ziegler JL: Treatment results of 54 American patients with Burkitt’s lymphoma are similar to the African experience. N Engl J Med 297: 75–80, 1977.

    PubMed  CAS  Google Scholar 

  102. Ziegler JL, Magrath IT, Olweny CLM: Long survival of Burkitt’s lymphoma in Uganda: A 10-year study. In: Seventieth Annual Meeting of the American Association for Cancer Research of the American Society of Clinical Oncologists. 1979, pp. 20: 430.

    Google Scholar 

  103. Milauskas MB, Berard CW, Young RC, Garvin AJ, Edwards BK, DeVita Jr VT: Undifferentiated non-Hodgkin’s lymphomas (Burkitt’s and non-Burkitt’s types). The relevance of making this histologic distinction. Cancer 2115–2121, 1982.

    Google Scholar 

  104. Lennert K, Mohri N: Histopathology and diagnosis of non-Hodgkin’s lmphomas. In: Malignant lymphomas other than Hodgkin’s disease. New York: Springer-Verlag. 1978, pp. 111–469.

    Google Scholar 

  105. Nathwani BN, Winberg CD: Non-Hodgkin’s lymphomas: An appraisal of the Working Formulation of Non-Hodgkin’s lymphomas for clinical usage. In: Malignant Lymphomas. A Pathology Annual Monograph. SC Sommers, PP Rosen (eds.) New York, Appleton-Century-Crofts, 1983, pp. 1–64.

    Google Scholar 

  106. Weisenburger DD, Nathwani BN, Diamond LW, Winberg CD, Rappaport H: Malignant lymphoma, intermediate lymphocyte type: A clinicopathologic study of 42 cases. Cancer 48: 1415–1425, 1982.

    Google Scholar 

  107. Weisenburger DD, Kim H, Rappaport H: Mantle-zone lymphoma: A follicular variant of intermediate lymphocytic lymphoma. Cancer 49: 1429–1438, 1982.

    PubMed  CAS  Google Scholar 

  108. Nathwani BN, Diamond LW, Winberg CD, Kim H, Bearman RM, Glick JH, Jones SE, Gams RA, Nissen NI, Rappaport H: Lymphoblastic lymphoma: A clinicopathologic study of 95 patients. Cancer 48: 2347–2357, 1981.

    PubMed  CAS  Google Scholar 

  109. Brouet JC, Labaume S, Seligmann M: Evaluation of T and B lymphocyte membrane markers in human non-Hodgkin’s malignant lymphomas. Br J Cancer (Suppl.) 31: 121–127, 1975.

    Google Scholar 

  110. Long JC, Aisenberg AC: Richter’s syndrome: A terminal complication of chronic lymphocytic leukemia with distinct clinicopathologic features. Am J Clin Pathol 63: 786–795, 1975.

    PubMed  CAS  Google Scholar 

  111. Richter MN: Generalized reticular cell sarcoma of lymph nodes associated with lymphatic leukemia. Am J Pathol 4: 285–292, 1928.

    PubMed  CAS  Google Scholar 

  112. Kjeldsberg CR, Marty J: Prolymphocytic transformation of chronic lymphocytic leukemia. Cancer 48: 2447–2457, 1981.

    PubMed  CAS  Google Scholar 

  113. Brouet JC, Mason DY, Danom F, Preud’home JL, Seligmann M, Reyes F, Navab F, Galian F, Rene E, Rambaud JC: Alpha-chain disease: Evidence for common clonal origin of intestinal immunoblastic lymphoma and plasmacytic proliferation. Lancet 1: 861, 1977.

    PubMed  CAS  Google Scholar 

  114. Galian A, Lecestre MJ, Scotto J, Bognel C, Matuchansky C, Rambaud JC: Pathological study of alpha-chain disease with special emphasis on evolution. Cancer 39: 2081–2101, 1977.

    PubMed  CAS  Google Scholar 

  115. Ramot B, Levanon M, Hahn Y, Lahat N, Moroz C: The mutual clonal origin of the lymphoplasmacytic and lymphoma cell in alpha-heavy chain disease. Clin Exp Immunol 27: 440–445, 1977.

    PubMed  CAS  Google Scholar 

  116. Anderson LG, Talal N: The spectrum of benign to malignant lymphoproliferation in Sjogren’s syndrome. Clin Exp Immunol 10: 199–221, 1972.

    PubMed  CAS  Google Scholar 

  117. Talal N, Bunim JJ: The development of malignant lymphoma in the course of Sjorgen’s syndrome. Clin Exp Immunol 10: 199–221, 1972.

    PubMed  Google Scholar 

  118. Talal N, Sokoloff L, Barth WF: Extra-salivary lymphoid abnormalities in Sjorgen’s syndrome (reticulum cell sarcoma, ‘pseudolymphoma’, macroglobulinemia). Am J Med 43: 50–65, 1967.

    PubMed  CAS  Google Scholar 

  119. Zulman J, Jaffe R, Talal N: Evidence that the malignant lymphoma of Sjogren’s syndrome is a monoclonal B-cell neoplasm. N Engl J Med 299: 1215–1220, 1978.

    PubMed  CAS  Google Scholar 

  120. Matas AJ, Hertel BF, Rosai J, Simmons RL, Najarian JS: Post-transplant malignant lymphoma: Distinctive morphologic features related to its pathogenesis. Am J Med 61: 716–720, 1976.

    PubMed  CAS  Google Scholar 

  121. Frizzera G, Hanto DW, Gajl-Peczalska KJ, Rosai J, McKenna RW, Sibley RK, Holahan KP, Lindequist LL: Polymorphic diffuse p-cell hyperplasias and lymphomas in renal transplant recipients. Cancer Res 41: 4262–4279, 1981.

    PubMed  CAS  Google Scholar 

  122. Lukes RJ, Tindle BH: Immunoblastic lymphadenopathy. A hyperimmune entity resembling Hodgkin’s disease. N Engl J Med 292: 1–8, 1975.

    PubMed  CAS  Google Scholar 

  123. Waldron J A, Leech JH, Glick A, Flexner JM, Collins RD: Malignant lymphoma of peripheral T-lymphocyte origin: Immunologic, pathologic and clinical features in six patients. Cancer 40: 1604–1617, 1977.

    PubMed  CAS  Google Scholar 

  124. Lukes RJ, Parker JW: The pathology of lymphoreticular neoplasms. In: The immunopathology of lymphoreticular neoplasms, Twomey JJ, Good RA (eds.), New York: Plenum Publishing, 1978, pp. 239–279.

    Google Scholar 

  125. Nathwani BN: A critical analysis of the classification of non-Hodgkin’s lymphoma. Cancer 44: 347–384, 1979.

    PubMed  CAS  Google Scholar 

  126. Nathwani BN, Winberg CD, Rappaport H, Zelman RJ: Malignant lymphoma, T-immunoblastic. A clinicopathologic and immunologic study of 41 patients. Blood 54 (Suppl. 1): 201a, 1979 (Abstr).

    Google Scholar 

  127. Nathwani BN, Metter GE, Gams RA, Bartolucci AA, Hartsock RJ, Neiman RS, Byrne GE Jr, Barcos M, Kim H, Rappaport H: Malignant lymphoma, mixed cell type, diffuse. Blood 62: 200–208, 1983.

    PubMed  CAS  Google Scholar 

  128. Schneider DR, Taylor CR, Parker JW, Cramer AS, Meyer PR, Lukes RJ: Immunoblastic sarcoma of T- and B-cell types: A morphologic comparison. Lab Invest 46:73a, 1982 (Abstr).

    Google Scholar 

  129. Levine AM, Taylor CR, Schneider DR, Koehler SC, Forman SJ, Lichtenstein A, Lukes RJ, Feinstein DI. Immunoblastic sarcoma of T-cell versus B-cell origin: I. Clinical features. Blood 58: 52–61, 1981.

    PubMed  CAS  Google Scholar 

  130. Palutke M, Tabaczka P, Weise RW, Axelrod A, Palacas C, Margolis H, Khilanani P, Ratanatharathorn M, Piligian J, Pollard R, Husain M: T-cell lymphomas of large cell type. Cancer 46: 87–101, 1980.

    PubMed  CAS  Google Scholar 

  131. Suchi T: Atypical lymph node hyperplasia with fatal outcome - A report on the histo- pathological, immunological, and clinical investigations of the cases. Recent adv in RES Res 14: 13–34, 1974.

    Google Scholar 

  132. Suchi T: ‘Atypical hyperplasia’ of lymph nodes with poor prognosis - Immunological characterization of the proliferating cells. Recent Adv in RES Research 18:124–133,1978.

    Google Scholar 

  133. Suchi T, Tajima K: Peripheral T-cell malignancy as a problem in Lymphoma classification. Jpn J Clin Oncol 9 (Suppl. 1), 443–450, 1979.

    Google Scholar 

  134. Kikuchi M, Mitsui T, Matsui N, Sato E, Tokunaga M, Hasui K, Ichimaru M, Kinoshita K,Kamihira S: T-cell malignancies in adults: Histopathological studies of lymph nodes in 110 patients. Jpn J Clin Oncol 9 (Suppl. 1), 407–422, 1979.

    Google Scholar 

  135. Watanabe S, Nakajima T, Shimosato Y, Shimoyama M, Minato K: T-cell malignancies: Subclassification and interrelationship. Jpn J Clin Oncol 9 (Suppl. 1), 423–442, 1979.

    Google Scholar 

  136. Shimoyama M, Minato K, Saito H, Takenaka T, Watanabe S, Nagatani T, Maruto M: Immunoblastic lymphadenopathy (IBL)-like T-cell lymphoma. Jpn J Clin Oncol 9 (Suppl. 1): 347–356, 1979.

    Google Scholar 

  137. Watanabe S, Shimosato Y, Shimoyama M, Minato K, Suzuki M, Abe M, Nagatani T: Adult T-cell lymphoma with hypergammaglobulinemia. Cancer 46: 2472–2483, 1980.

    PubMed  CAS  Google Scholar 

  138. Portlock CS, Rosenberg SA: Chemotherapy of the non-Hodgkin’s lymphomas: The Stanford experience. Cancer Treat Rep 61: 1049–1055, 1977.

    PubMed  CAS  Google Scholar 

  139. Ezdinli EZ, Costello W, Wasser LP, Lenhard RE, Berard CW, Hartsock J, Bennett JM, Carbone PP: Eastern Cooperative Oncology Group experience with the Rappaport classification of non-Hodgkin’s lymphomas. Cancer 43: 544–550, 1979.

    PubMed  CAS  Google Scholar 

  140. Glick JH: Chemotherapy of Hodgkin’s lymphomas. In: Lymphomas 1 including Hodgkin’s disease Bennet JM (ed.), The Hague, Boston, London: Martinus Nijhoff Publishers, 1981, pp. 343–446.

    Google Scholar 

  141. Ezdinli EZ, Costello W, Lenhard Jr RE, Bakemeier R, Bennett JM, Berard CW, Carbonne PP: Survival of nodular versus diffuse pattern lymphocytic poorly differentiated lymphoma. Cancer 41: 1990–1996, 1978.

    Google Scholar 

  142. Rudders RA, Kaddis M, DeLellis RA, Casey Jr H: Nodular non-Hodgkin’s lymphoma (NHL). Factors influencing prognosis and indications for aggressive treatment. Cancer 43: 1643–1651, 1979.

    PubMed  CAS  Google Scholar 

  143. Anderson T, Bender BA, Fisher RI, DeVita VT, Chabner BA, Berard CW, Norton L, Young RC: Combination chemotherapy in non-Hodgkin’s lymphoma: Results of long-term follow-up. Cancer Treat Rep 61: 1057–1066, 1977.

    PubMed  CAS  Google Scholar 

  144. Bitran JC, Golomb HM, Ultman JE, Sweet Jr DL, Lester EP, Stein RS, Miller JB, Moran EM, Kinnealey, Vardiman JE, Kinzie J, Roth NO: Non-Hodgkin’s lymphoma, poorly differentiated lymphocytic and mixed cell types: Results of sequential staging proc, Berardresponse to therapy, and survival of 100 patients. Cancer 42: 88–95, 1978.

    PubMed  CAS  Google Scholar 

  145. Ezdinli EZ, Costello WB, Icli F, Lenhard RE, Johnson GJ, Silverstein M, Berard CW, Bennett JM, Carbone PP: Nodular mixed lymphocytic-histiocytic lymphoma: Response and survival. Cancer 45: 261–267, 1980.

    PubMed  CAS  Google Scholar 

  146. Glick JH, Barnes JM, Ezdinli EZ, Berard CW, Orlow EL, Bennett JM: Nodular mixed lymphoma: Results of randomized trial failing to confirm prolonged disease-free survival with COPP chemotherapy. Blood 58: 920–925, 1981.

    PubMed  CAS  Google Scholar 

  147. Colby TV, Hoppe RT, Burke JS: Nodular lymphoma: Clinicopathologic correlations of parafollicular small lymphocytes and degree of nodularity. Cancer 45: 2364–2367, 1980.

    PubMed  CAS  Google Scholar 

  148. Longo D, Hubbard S, Wesley M, Jaffe E, Chabner B, DeVita VT, Young R: Prolonged initial remission in patients with nodular mixed lymphoma. Proc Am Soc Oncol 22: 521, 1981.

    Google Scholar 

  149. Osborne CK, Norton L, Young RC, Garvin AJ, Simon RM, Berard CW, Hubbard S, DeVita VT: Nodular histiocytic lymphoma: An aggressive nodular lymphoma with potential for prolonged disease-free survival. Blood 56: 98–102, 1980.

    PubMed  CAS  Google Scholar 

  150. Glick JH, McFadden E, Costello W, Ezdinli EZ, Berard CW, Bennett JM: Nodular histiocytic lymphoma: Factors influencing prognosis and implications for aggressive chemotherapy. Cancer 49: 840–845, 1982.

    PubMed  CAS  Google Scholar 

  151. Fuller LM, Banker FL, Butler JJ, Gamble JF, Sullivan MP: The natural history of non- Hodgkin’s lymphomata stages I and II. Br J Cancer (Suppl. 11) 31: 270–285, 1975.

    Google Scholar 

  152. Rosenberg SA, Dorfman RF, Kaplan HS: The value of sequential bone marrow biopsy and laparotomy and splenectomy in a series of 127 consecutive untreated patients with non- Hodgkin’s lymphoma. Br J Cancer (Suppl. 11) 31: 221–227, 1975.

    Google Scholar 

  153. Stein RS, Ultmann JE, Byrne Jr GE, Moran EM, Golomb HM, Oetzel N: Bone marrow involvement in non-Hodgkin’s lymphoma. Implications for staging and therapy. Cancer 37: 629–636, 1976.

    PubMed  CAS  Google Scholar 

  154. Jones SE, Butler JJ, Byrne GE, Coltman CA, Moon TE: Histopathologic review of lymphoma cases from the Southwest Oncology Group. Cancer 39: 1071–1076, 1977.

    PubMed  CAS  Google Scholar 

  155. Byrne GE: Rappaport classification of non-Hodgkin’s lymphoma: histologic features and clinical significance. Cancer Treat Rep 61: 935–944, 1977.

    PubMed  Google Scholar 

  156. Coltman CA, Gams RA, Glick JH, Jenkin RD: Lymphoma. In: Cancer research. Impact of the cooperative groups, Hoogstraten B (ed.), New York: Masson Publishing USA, Inc., 1980, pp. 39–84.

    Google Scholar 

  157. Velez-Garcia E, Durant J, Gams R, Bartolucci A: Results of a uniform histopathologic review system of lymphoma cases: A ten-year study from the Southeastern Cancer Study Group. Cancer 52: 675–679, 1983.

    PubMed  CAS  Google Scholar 

  158. Icli F, Ezdinli EZ, Costello W, Berard CW, Bennett JM, Carbone PP: Diffuse well- differentiated lymphocytic lymphoma (DLWD). Response and survival. Cancer 42: 1936–1942, 1978.

    PubMed  CAS  Google Scholar 

  159. Evans HL, Butler JJ, Youness EL: Malignant lymphoma, small lymphocytic type. Cancer 41: 1440–1455, 1978.

    PubMed  CAS  Google Scholar 

  160. Braylan RC, Jaffe ES, Burbach JW, Frank MM, Johnson RC, Berard CW: Similarities of surface characteristics of neoplastic well-differentiated lymphocytes from solid tissues and from peripheral blood. Cancer Res 36: 1619–1625, 1976.

    PubMed  CAS  Google Scholar 

  161. Kim H, Heller P. Rappaport H: Monoclonal gammopathies associated with lymphoprolifera- tive disorders: A morphologic study. Am J Clin Pathol 59: 282–294, 1973.

    PubMed  CAS  Google Scholar 

  162. Stein H, Petersen N, Gaedicke G, Lennert K, Landbeck G: Lymphoblastic lymphoma of convoluted or acid phosphatase type - A tumor of T precursor cells. Int J Cancer 17: 292–295, 1976.

    PubMed  CAS  Google Scholar 

  163. Jaffe ES, Braylan RC, Frank MM, Green L, Berard CW: Heterogeneity of immunologic markers and surface morphology in childhood lymphoblastic lymphoma. Blood 48: 213–222, 1976.

    PubMed  CAS  Google Scholar 

  164. Koziner B, Fillippa DA, Mertelsmann R, Gupta S, Clarkson B, Good RA, Siegal FP: Characterization of malignant lymphomas in leukemic phase by multiple differentiation markers of mononuclear cells. Correlation with clinical features and conventional morphology. Am J Med 63: 556–567, 1977.

    PubMed  CAS  Google Scholar 

  165. Bloomfield CD, Frizzera G, Gail-Peczalska KJ, Brunning RD, Kersey J: Malignant lymphoma, lymphoblastic (MLLB) in the adult. (Abstr) Proc Am Soc Clin Oncol 19: 378, 1978.

    Google Scholar 

  166. Long JC, McCaffrey RP, Aisenberg AC, Marks SM, Kung PC: Terminal deoxynucleotidyl transferase positive lymphoblastic lymphoma. A study of 15 cases. Cancer 44: 2127–2139, 1979.

    PubMed  CAS  Google Scholar 

  167. Cossman J, Chused TM, Bollum F, Jaffe ES: Diversity of Immunologic phenotype of lymphoblastic lymphoma. Cancer Res (in press).

    Google Scholar 

  168. Lukes RJ, Collins RD: New observations on follicular lymphoma. In: Malignant diseases of the hematopoietic system. GANN Monograph on Cancer research, no. 15, Akazaki K, Rappaport H, Berard CW, Bennett JM, Ishikawa E (eds.), Tokyo: University of Tokyo Press, 1973, pp. 209–215.

    Google Scholar 

  169. Lukes RJ, Collins RD: A functional classification of malignant lymphomas. In: The re-ticuloendothelial system, IAP Monograph No. 16, Rebuck JW, Berard CW, Abell MR (eds.), Baltimore: Williams and Wilkins, 1975, pp. 213–242.

    Google Scholar 

  170. Lukes RJ, Collins RD: New approaches to the classification of the lymphomata. Br J Cancer (Suppl. 11) 31: 1–28, 1975.

    Google Scholar 

  171. Lukes RJ, Collins RD: Lukes-Collins classification and its significance. Cancer Treat Rep 61: 971–979, 1977.

    PubMed  CAS  Google Scholar 

  172. Lukes RJ: Functional classification of malignant lymphoma of Lukes and Collins. Recent Results Cancer Res 64: 19–30, 1978.

    PubMed  CAS  Google Scholar 

  173. Lukes RJ, Lincoln TL, Parker JW, Alavaikko MJ: Cold Spring Harbor Conferences on Cell Proliferation. In: Differentiation of normal neoplastic hematopoietic cells. Clarkson B, Marks PA, Tills JE (eds.) An immunologic approach to classification of malignant lymphomas: A cytokinetic model of lymphoid neoplasia. USA Vol. 5. 1978, pp. 935–952.

    Google Scholar 

  174. Lukes RJ: The immunologic approach to the pathology of malignant lymphomas. Am J Clin Pathol 72: 657–669, 1979.

    PubMed  CAS  Google Scholar 

  175. Lukes RJ, Taylor CR, Parker JW: In: Malignant lymphoma: Immunological surface marker studies in the histopathological diagnosis of non-Hodgkin’s lymphomas based on multiparameter studies of 790 cases. Bristol Meyer: Academic Press, 1982, pp. 310–347.

    Google Scholar 

Download references

Authors
  1. Bharat N. Nathwani
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Medical Oncology Division, Cancer Center of the University of Rochester Medical Center, Rochester, New York, USA

    John M. Bennett M.D. (Head) (Head)

Rights and permissions

Reprints and permissions

Copyright information

© 1983 Martinus Nijhoff Publishers, Boston.

About this chapter

Cite this chapter

Nathwani, B.N. (1983). The Rappaport classification of the non-Hodgkin’s lymphomas: Is it pertinent for the 1980’s?. In: Bennett, J.M. (eds) Controversies in the Management of Lymphomas. Cancer Treatment and Research, vol 16. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-3885-7_9

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-3885-7_9

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-3887-1

  • Online ISBN: 978-1-4613-3885-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation